Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1088 blog entries.

February 2024

PathAI Launches New Pathologist-Centric Features on AISight to Enable Efficient Case Review through Intelligent Case Prioritization and Real-Time Multi-Institutional Collaboration

2024-02-28T10:31:28+00:00

PathAI, Inc., a leading AI-powered precision pathology company, today announced the availability of two new features on the AISight digital pathology image management system – an Intelligent Caselist and AISight Live. AISight is a cloud-based platform that serves as a central hub for case management, image management, and best-in-class artificial intelligence to enable efficient end-to-end digital pathology workflows. The latest AISight enhancements represent PathAI’s ongoing commitment to empowering pathologists with cutting-edge solutions that improve pathology assessment and laboratory operations and lay the groundwork for broader implementation of AI tools in pathology.

PathAI Launches New Pathologist-Centric Features on AISight to Enable Efficient Case Review through Intelligent Case Prioritization and Real-Time Multi-Institutional Collaboration2024-02-28T10:31:28+00:00

12 Years of Digital Pathology Innovation and What to Expect Next With Kate Lillard Tunstall, Indica Labs

2025-05-06T12:41:36+00:00

The Future Landscape of Digital Pathology: Insights from Kate Lillard Tunstall, Indica Labs

12 Years of Digital Pathology Innovation and What to Expect Next With Kate Lillard Tunstall, Indica Labs2025-05-06T12:41:36+00:00

Evaluating Advancements in AI Algorithms for White Blood Cell Identification in Hematologic Malignancies

2025-06-26T15:48:36+00:00

Artificial intelligence (AI) systems have been developed to automate and improve the accuracy of blood film analysis. One of these AI systems is Techcyte, a web-based platform that can analyze blood films scanned by any digital microscope and provide white blood cell (WBC) differentials and blast identification. Techcyte uses deep machine learning to refine its algorithms and increase its accuracy over time. But how much has Techcyte improved since its first release in 2019?

Evaluating Advancements in AI Algorithms for White Blood Cell Identification in Hematologic Malignancies2025-06-26T15:48:36+00:00

Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data

2024-02-27T13:00:51+00:00

Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images CAMBRIDGE, Mass. and PHILADELPHIA  – February 27, 2024 – Proscia®, a leading provider of digital and computational pathology solutions, today announced that Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, is now a Proscia Ready partner. Pramana joins the partner [...]

Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data2024-02-27T13:00:51+00:00

Supplementary Webinar Q&A

2024-02-26T11:04:09+00:00

Pathology News was delighted to present the webinar "Precision in Prostatectomy: The Synergy Between Robot-Assisted Radical Prostatectomy and the Histolog Scanner," in collaboration with Saman Tree Medical on February 7, 2024. Given the overwhelming number of questions, it was impossible to address all questions during the event. To remedy this, we've compiled this supplementary Q&A article. Here, our esteemed speakers, Prof. Greg Shaw, and Prof. Alexandre Mottrie are joined by Dr. Aiman Haider, a Consultant Histopathologist, who generously offer their insights in response to the audience’s questions.

Supplementary Webinar Q&A2024-02-26T11:04:09+00:00

Milestone at Vienna General Hospital: VivaScope Revolutionises Cancer Diagnosis and Treatment in Austria

2024-02-23T11:36:52+00:00

In Austria, around 42,000 people are diagnosed with cancer every year. Although this is a matter of health and therefore the greatest human good, the analogue frozen section – a technique first used in 1895 – is still considered the gold standard for intraoperative pathological assessment when removing tumour tissue. With its “Ex Vivo” technology, the company VivaScope is bringing about a fundamental medical revolution. Thanks to digital optical sections, tumour tissue can be removed more efficiently than ever before and assessed within five minutes using telemedicine. The VivaScope 2500 is now being used for the first time in the field of dermatology at Vienna General Hospital.

Milestone at Vienna General Hospital: VivaScope Revolutionises Cancer Diagnosis and Treatment in Austria2024-02-23T11:36:52+00:00

Raising The Bar in Specimen Quality With The Lumea BxChip®

2026-09-16T12:58:33+00:00

In the ever-evolving landscape of medical histopathology, the quest for efficiency, standardization, and cost-effectiveness has driven groundbreaking innovations. At the forefront of this revolution is the BxChip® technology by Lumea, a transformative tissue microarray (TMA). This article delves into the exceptional features and benefits of BxChip, highlighting its impact on reducing costs, improving tissue yield and quality to enhance diagnosis, and revolutionizing histological processes.

Raising The Bar in Specimen Quality With The Lumea BxChip®2026-09-16T12:58:33+00:00

Diagnexia Partners with Aga Khan University Hospital to Enhance Pathology Services and Foster AI Diagnostic Innovations

2024-02-21T13:08:58+00:00

Diagnexia, a leader in pathology expertise, is thrilled to announce a significant collaborative agreement with Aga Khan University Hospital (AKUH), Nairobi. This partnership marks a strategic step in enhancing pathology services and spearheading advancements in AI-driven diagnostics.

Diagnexia Partners with Aga Khan University Hospital to Enhance Pathology Services and Foster AI Diagnostic Innovations2024-02-21T13:08:58+00:00

Proscia Forms New Alliance To Help Laboratories Accelerate Scaled Adoption Of Digital Pathology With Confidence

2024-02-21T11:36:10+00:00

As laboratories expand their digital pathology practices beyond basic image viewing and deploy artificial intelligence (AI), they must implement the right hardware and software solutions to meet their specific goals. These technologies, when successfully integrated in routine practice, can drive efficiencies, improve confidence, and unlock new insights. Even still, the need for multiple solutions can leave laboratories feeling hampered in their ability to scale. They may face a lack of certainty in their selections, limited investment protection, and the increased overhead of working with several vendors.

Proscia Forms New Alliance To Help Laboratories Accelerate Scaled Adoption Of Digital Pathology With Confidence2024-02-21T11:36:10+00:00

Deciphex Enables First Digital GLP Peer Review Conducted by a Consultant for a Contract Research Provider

2024-02-20T15:48:14+00:00

In 2023, a Toxicological Pathologist at Integrated Biologix GmbH, Sarah Taplin, became the first consultant pathologist to perform a regulated digital peer review for a study conducted at a drug development research provider. In this case, Integrated Biologix GmbH, a consultancy firm for the nonclinical development of biotherapeutics, partnered with Labcorp, a global leader of innovative and comprehensive laboratory services. This achievement was made possible with the use of the Patholytix digital pathology platform, the flagship product of Deciphex.

Deciphex Enables First Digital GLP Peer Review Conducted by a Consultant for a Contract Research Provider2024-02-20T15:48:14+00:00
Legal

Bioincyte Ltd is registered in the United Kingdom
under company number 13037659

Get in touch

© Copyright 2025, Bioincyte Ltd

Fields marked with an asterisk (*) are required.
By submitting you agree to our T&C and Privacy Policy

Go to Top